Diffusion imaging in gliomas: how ADC values forecast glioma genetics

Area of Science:

• Neuroimaging
• Oncology
• Radiology

Background:

• Gliomas are primary brain tumors with diverse genetic profiles.
• Accurate non-invasive prediction of glioma genetics is crucial for treatment planning.
• Current diagnostic methods often require invasive biopsies.

Purpose of the Study:

• To investigate the correlation between diffusion-weighted imaging (DWI) and mean apparent diffusion coefficient (ADC) values and glioma genetic/molecular features.
• To establish imaging biomarkers for non-invasive tumor characterization.
• To support personalized treatment strategies for glioma patients.

Main Methods:

• Analysis of 91 glioma patients with preoperative MRI, including DWI.
• Collection of histopathological and genetic data (IDH1, MGMT, EGFR, TERT, CDKN2A).
• Statistical analysis to correlate ADC values and MRI parameters with genetic characteristics.

Main Results:

• Lower ADC values were significantly associated with aggressive glioma features (IDH1-wildtype, MGMT unmethylated, TERT variant, EGFR amplification).
• Distinct ADC patterns were observed in gliomas with specific gene deletions (CDKN2A, TP53, PTEN).
• Contrast enhancement and other MRI parameters supported these findings in tumor characterization.

Conclusions:

• DWI and ADC measurements show significant potential as non-invasive predictors of glioma genetics.
• These imaging biomarkers can aid in glioma characterization.
• Findings provide valuable insights for guiding personalized treatment strategies in neuro-oncology.